Session Information
AABB Annual Meeting & CTTXPO 2011
Click here to go to the previous page
Components and Component Processing: Platelets and Plasma
Track
:
Oral Abstracts
Program Code:
040A
Date:
Tuesday, October 25, 2011
Time:
2:00 PM to 3:30 PM
PST
Location:
28 A/B
MODERATOR
(S):
Ralph Vassallo, MD, FACP, Heritage Division Chief Medical Officer, American Red Cross Biomedical Services
Andy Heaton, MD
- Describe how platelet additive solutions are able to provide products with a decreased titer of Anti-A and —B.
- Discuss how the inhibition of p38 mitogen activated protein kinase improves in vitro parameters and decreases platelet glycolysis during 7 day storage.
- Understand the effects of Mirasol PRT Treated Platelet products in autologous stem cell transplant patients.
| CE Category | CE Value |
|---|---|
| California Clinical Laboratory Personnel | 1.5 |
| California Nurse | 1.8 |
| Florida Laboratory Personnel | 1.8 |
| General Attendee | 1.5 |
| Physician | 1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
This session is a part of:
 | Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or reproduction of any materials herein is strictly prohibited. |  |